Health

Extended-Release Stimulants for ADHD: FDA Drug Safety Communication - FDA Requires Expanded Labeling about Weight Loss Risk in Patients Younger than 6 Years

DailyTrendDailyTrend
Jul 3, 2025 - 12:00
 0  0
Extended-Release Stimulants for ADHD: FDA Drug Safety Communication - FDA Requires Expanded Labeling about Weight Loss Risk in Patients Younger than 6 Years
The FDA is revising the labeling of all extended-release stimulants indicated to treat attention-deficit/hyperactivity disorder (ADHD) - including certain formulations of amphetamine and methylphenidate - to warn about the risk of weight loss and other adverse reactions (side effects) in patients yo
Read More

What's Your Reaction?

Like Like 0
Dislike Dislike 0
Love Love 0
Funny Funny 0
Angry Angry 0
Sad Sad 0
Wow Wow 0
DailyTrend
DailyTrend

Related Posts

Sandoz Inc. Issues Voluntary Nationwide Recall of One Lot of Cefazolin for Injection Due to Product Mispackaging

Sandoz Inc. Issues Voluntary Nationwide Recall of One L...

DailyTrend Jun 28, 2025  0  0

FDA Grants Accelerated Approval to Lynozyfic (linvoseltamab-gcpt) for Treatment of Relapsed or Refractory Multiple Myeloma

FDA Grants Accelerated Approval to Lynozyfic (linvoselt...

DailyTrend Jul 3, 2025  0  0

Takeda Announces U.S. FDA Approval of Gammagard Liquid ERC, the Only Ready-to-Use Liquid Immunoglobulin Therapy with Low Immunoglobulin A (IgA) Content

Takeda Announces U.S. FDA Approval of Gammagard Liquid ...

DailyTrend Jul 2, 2025  0  0

U.S. Food and Drug Administration Approves Streamlined Patient Monitoring Requirements and Removal of REMS Programs within Bristol Myers Squibb’s Cell Therapy Labels for Breyanzi and Abecma

U.S. Food and Drug Administration Approves Streamlined ...

DailyTrend Jul 1, 2025  0  0

Lucian Leape, Whose Work Spurred Patient Safety in Medi...

DailyTrend Jul 2, 2025  0  0

Don’t Like Eating Insects? Your Pet Might.

Don’t Like Eating Insects? Your Pet Might.

DailyTrend Jul 3, 2025  0  0